iShares Morningstar Small-Cap ETF (ISCB)
| Assets | $238.31M |
| Expense Ratio | 0.04% |
| PE Ratio | 17.63 |
| Shares Out | 4.00M |
| Dividend (ttm) | $0.81 |
| Dividend Yield | 1.36% |
| Ex-Dividend Date | Jun 16, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 23.95% |
| Volume | 3,181 |
| Open | 59.99 |
| Previous Close | 59.56 |
| Day's Range | 59.91 - 60.00 |
| 52-Week Low | 46.59 |
| 52-Week High | 64.66 |
| Beta | 1.11 |
| Holdings | 1586 |
| Inception Date | Jun 28, 2004 |
About ISCB
Fund Home PageThe iShares Morningstar Small-Cap ETF (ISCB) is an exchange-traded fund that is based on the Morningstar US Small Cap Extended index, a market-cap-weighted index of US small-cap stocks ISCB was launched on Jun 28, 2004 and is issued by BlackRock.
Top 10 Holdings
2.79% of assets| Name | Symbol | Weight |
|---|---|---|
| BlackRock Cash Funds Treasury SL Agency | XTSLA | 0.34% |
| RUSSELL 2000 EMINI CME SEP 25 | n/a | 0.33% |
| Woodward, Inc. | WWD | 0.29% |
| TechnipFMC plc | FTI | 0.28% |
| Coherent Corp. | COHR | 0.27% |
| Credo Technology Group Holding Ltd | CRDO | 0.26% |
| Carpenter Technology Corporation | CRS | 0.26% |
| ITT Inc. | ITT | 0.26% |
| BWX Technologies, Inc. | BWXT | 0.25% |
| Neurocrine Biosciences, Inc. | NBIX | 0.25% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 16, 2025 | $0.18753 | Jun 20, 2025 |
| Mar 18, 2025 | $0.16182 | Mar 21, 2025 |
| Dec 17, 2024 | $0.24065 | Dec 20, 2024 |
| Sep 25, 2024 | $0.22478 | Sep 30, 2024 |
| Jun 11, 2024 | $0.15412 | Jun 17, 2024 |
| Mar 21, 2024 | $0.1478 | Mar 27, 2024 |
Performance
ISCB had a total return of 13.27% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.18%.
News
ISCB: This Low-Cost Small-Cap ETF Disappoints On Performance And Fundamentals
ISCB offers diversified exposure to over 1,500 U.S. small-cap securities. Its 0.04% expense ratio is among the best in its category, though the ETF manages just $232 million in assets. Shareholders ha...
Owning Small-Cap ETFs Still Looks Attractive Even After A Strong Run
Except for Micro-Cap stocks, Small-Cap stocks have been the best-performing size since last fall. I listed some expert views where they might go from here, not all are positive.
Small-Caps Surge: What Now In 2021?
Positive vaccine news boosted hopes for an economic reopening in 2021, which flipped market signals, and small caps and value stocks rallied strongly in November. The Russell 2000 Index, a gauge of U....